(no text — see the shared post below)

YELLOW-III reversed total atheroma volume 4.4% in 6 months at LDL of about 39 mg/dL
Louis adds a green dot for YELLOW-III to his plaque-reversal chart. High-dose statin plus a PCSK9 inhibitor reduced total atheroma volume from 137.2 to about 131 mm3 in only 6 months and stabilized plaque, with post-treatment LDL averaging 39.1 mg/dL.



